PE20131116A1 - AMPA ENHANCING HETEROCYCLIC COMPOUNDS - Google Patents
AMPA ENHANCING HETEROCYCLIC COMPOUNDSInfo
- Publication number
- PE20131116A1 PE20131116A1 PE2013000244A PE2013000244A PE20131116A1 PE 20131116 A1 PE20131116 A1 PE 20131116A1 PE 2013000244 A PE2013000244 A PE 2013000244A PE 2013000244 A PE2013000244 A PE 2013000244A PE 20131116 A1 PE20131116 A1 PE 20131116A1
- Authority
- PE
- Peru
- Prior art keywords
- thadiazine
- dihydropyride
- ring
- ampa
- enhancing
- Prior art date
Links
- MGRVRXRGTBOSHW-UHFFFAOYSA-N (aminomethyl)phosphonic acid Chemical compound NCP(O)(O)=O MGRVRXRGTBOSHW-UHFFFAOYSA-N 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- -1 4-PHENOXYPHENYL Chemical class 0.000 abstract 3
- 206010020772 Hypertension Diseases 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- UUDAMDVQRQNNHZ-UHFFFAOYSA-N (S)-AMPA Chemical compound CC=1ONC(=O)C=1CC(N)C(O)=O UUDAMDVQRQNNHZ-UHFFFAOYSA-N 0.000 abstract 1
- KEIFWROAQVVDBN-UHFFFAOYSA-N 1,2-dihydronaphthalene Chemical compound C1=CC=C2C=CCCC2=C1 KEIFWROAQVVDBN-UHFFFAOYSA-N 0.000 abstract 1
- 102000003678 AMPA Receptors Human genes 0.000 abstract 1
- 108090000078 AMPA Receptors Proteins 0.000 abstract 1
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 150000001924 cycloalkanes Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003334 potential effect Effects 0.000 abstract 1
- 239000004576 sand Substances 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
REFERIDA A UN COMPUESTO HETEROCICLICO DE FORMULA (I), DONDE EL ANILLO A ES UN HETEROCICLO DE 5 A 7 MIEMBROS OPCIONALMENTE SUSTITUIDO; EL ANILLO B ES UN HETEROCICLO DE 5 A 8 MIEMBROS OPCIONALMENTE SUSTITUIDO; EL ANILLO D ES CICLOALCANO C3-C7, ARENO C6-C14, DIHIDRONAFTALENO, ENTRE OTROS; W ES ALQUILENO C1-C3 O ALQUENILENO C2-C3 OPCIONALMENTE SUSTITUIDOS; L ES UN ENLACE, O, O-CH2, CO-NH, ENTRE OTROS; n ES 0, 1 O 2. SON COMPUESTOS PREFERIDOS: 2,2-DIOXIDO DE 9-(4-FENOXIFENIL)-3,4-DIHIDROPIRIDO[2,1-c][1,2,4]TIADIAZINA, 2,2-DIOXIDO DE 9-[4-(4-METILFENOXI)FENIL]-3,4-DIHIDROPIRIDO[2,1-c][1,2,4]TIADIAZINA, 2,2-DIOXIDO DE 9-[4-(CICLOHEXILOXI)FENIL]-3,4-DIHIDROPIRIDO[2,1-c][1,2,4]TIADIAZINA, ENTRE OTROS. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS TIENEN ACCION POTENCIADORA DEL RECEPTOR DE AMPA (ACIDO ALFA-AMINO-3-HIDROXI-5-METIL-4-ISOXAZOLPROPIONICO) Y SON UTILES EN EL TRATAMIENTO DE LA DEPRESION, ESQUIZOFRENIA, ENFERMEDAD DE ALZHEIMER, TRANSTORNO DE HIPERACTIVIDAD, ENTRE OTRASREFERRED TO A HETEROCICLIC COMPOUND OF FORMULA (I), WHERE THE RING A IS A HETEROCICLE OF 5 TO 7 MEMBERS OPTIONALLY SUBSTITUTED; RING B IS AN OPTIONALLY REPLACED 5 TO 8 MEMBER HETERO CYCLE; RING D IS C3-C7 CYCLOALKANE, C6-C14 SAND, DIHYDRONAPHTHALENE, AMONG OTHERS; W IS C1-C3 ALKYLENE OR C2-C3 ALKYLENE OPTIONALLY SUBSTITUTED; L IS A LINK, O, O-CH2, CO-NH, AMONG OTHERS; n IS 0, 1 OR 2. PREFERRED COMPOUNDS ARE: 2,2-DIOXIDE OF 9- (4-PHENOXYPHENYL) -3,4-DIHYDROPYRIDE [2,1-c] [1,2,4] THADIAZINE, 2,2 -9- [4- (4-METHYLPHENOXY) PHENYL] -3,4-DIHYDROPYRIDE [2,1-c] [1,2,4] THADIAZINE, 2,2-DIOXIDE OF 9- [4- (CYCLOHEXYLOXY ) PHENYL] -3,4-DIHYDROPYRIDE [2,1-c] [1,2,4] THADIAZINE, AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS HAVE A POTENTIAL ACTION ON THE AMPA RECEPTOR (ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLPROPIONIC ACID) AND ARE USEFUL IN THE TREATMENT OF DEPRESSION, SCHIZOPHRENIA, Hypertension, Hypertension disease, Hypertension disease.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010179577 | 2010-08-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20131116A1 true PE20131116A1 (en) | 2013-10-24 |
Family
ID=44534564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2013000244A PE20131116A1 (en) | 2010-08-10 | 2011-08-09 | AMPA ENHANCING HETEROCYCLIC COMPOUNDS |
Country Status (39)
| Country | Link |
|---|---|
| US (11) | US8575154B2 (en) |
| EP (1) | EP2603513B1 (en) |
| JP (2) | JP5788496B2 (en) |
| KR (1) | KR101852215B1 (en) |
| CN (2) | CN103180326B (en) |
| AR (1) | AR082618A1 (en) |
| AU (1) | AU2011290126B2 (en) |
| BR (1) | BR112013002250B1 (en) |
| CA (1) | CA2807460C (en) |
| CL (1) | CL2013000380A1 (en) |
| CO (1) | CO6680700A2 (en) |
| CR (1) | CR20130066A (en) |
| CY (1) | CY1123507T1 (en) |
| DK (1) | DK2603513T3 (en) |
| DO (1) | DOP2013000030A (en) |
| EA (1) | EA022078B1 (en) |
| EC (1) | ECSP13012478A (en) |
| ES (1) | ES2793723T3 (en) |
| GE (1) | GEP20156216B (en) |
| HR (1) | HRP20200844T1 (en) |
| HU (1) | HUE049460T2 (en) |
| IL (1) | IL224452A (en) |
| LT (1) | LT2603513T (en) |
| MA (1) | MA34509B1 (en) |
| MX (1) | MX349470B (en) |
| MY (1) | MY165908A (en) |
| NZ (1) | NZ607593A (en) |
| PE (1) | PE20131116A1 (en) |
| PH (1) | PH12013500247A1 (en) |
| PL (1) | PL2603513T3 (en) |
| PT (1) | PT2603513T (en) |
| RS (1) | RS60311B1 (en) |
| SG (1) | SG187656A1 (en) |
| SI (1) | SI2603513T1 (en) |
| TW (1) | TWI504604B (en) |
| UA (1) | UA111594C2 (en) |
| UY (1) | UY33551A (en) |
| WO (1) | WO2012020848A1 (en) |
| ZA (1) | ZA201301120B (en) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2603513T (en) * | 2010-08-10 | 2020-06-08 | Takeda Pharmaceuticals Co | Heterocyclic compound and use thereof |
| JP5976011B2 (en) * | 2011-04-05 | 2016-08-23 | 武田薬品工業株式会社 | Sulfonamide derivatives and uses thereof |
| JP6134654B2 (en) * | 2012-02-08 | 2017-05-24 | 武田薬品工業株式会社 | Heterocyclic compounds and uses thereof |
| BR112015031249A2 (en) * | 2013-06-13 | 2017-07-25 | Veroscience Llc | treatment method, method for treating a metabolic disorder or a key element thereof, method for normalizing a daily dopamine release rate in the sumn, method for stimulating dopamine release from dopaminergic neurons in an individual's sumn and pharmaceutical composition |
| PT3421462T (en) | 2013-06-27 | 2023-06-29 | Pfizer | Heteroaromatic compounds and their use as dopamine d1 ligands |
| US11589583B2 (en) | 2013-12-03 | 2023-02-28 | Fmc Corporation | Pyrrolidinones herbicides |
| KR102395827B1 (en) | 2013-12-03 | 2022-05-10 | 에프엠씨 코포레이션 | Pyrrolidinones as herbicides |
| US9944602B2 (en) | 2014-07-02 | 2018-04-17 | E. I. Du Pont De Nemours And Company | Piperidinone herbicides |
| KR102542215B1 (en) | 2014-12-08 | 2023-06-12 | 에프엠씨 코포레이션 | 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones |
| AU2016246410B2 (en) | 2015-04-10 | 2020-11-05 | Fmc Corporation | Substituted cyclic amides as herbicides |
| EP3288928B1 (en) | 2015-04-27 | 2021-10-13 | FMC Corporation | Butyrolactones as herbicides |
| MA41988B1 (en) * | 2015-04-29 | 2021-03-31 | Janssen Pharmaceutica Nv | Azabenzimidazoles and their use as ampa receptor modulators |
| AU2016255431B2 (en) * | 2015-04-29 | 2020-05-07 | Janssen Pharmaceutica Nv | Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators |
| EP3294743B1 (en) | 2015-05-12 | 2019-08-21 | FMC Corporation | Aryl substituted bicyclic compounds as herbicides |
| BR112017022743B1 (en) | 2015-05-29 | 2022-02-22 | Fmc Corporation | Compost, herbicide compositions, herbicide mixture and method for controlling the growth of unwanted vegetation |
| CN107709310B (en) | 2015-06-02 | 2021-09-24 | Fmc公司 | Substituted cyclic amides and their use as herbicides |
| WO2017023515A1 (en) | 2015-07-31 | 2017-02-09 | E. I. Du Pont De Nemours And Company | Cyclic n-carboxamide compounds useful as herbicides |
| HRP20191589T1 (en) * | 2015-08-06 | 2019-12-13 | Hoffmann La Roche | PROCEDURES FOR PREPARATION OF GALNAC ACID DERIVATIVES |
| US20170181292A1 (en) * | 2015-12-16 | 2017-06-22 | Rohm And Haas Electronic Materials Llc | Method for forming organic coating on nickel surface |
| CN105669731B (en) * | 2016-01-10 | 2017-06-30 | 沧州普瑞东方科技有限公司 | A kind of synthetic method of 4 (4 alkyl epoxide) phenyl boric acids |
| ES2958741T3 (en) | 2016-12-21 | 2024-02-14 | Fmc Corp | Nitrone herbicides |
| CN107892697B (en) | 2016-12-26 | 2020-11-03 | 郑州泰基鸿诺医药股份有限公司 | [1,3] thiazine-2-amine compound and application and pharmaceutical composition thereof |
| JP7548697B2 (en) | 2017-03-21 | 2024-09-10 | エフ エム シー コーポレーション | Herbicidal mixtures, compositions, and methods |
| EP3599854A4 (en) | 2017-03-21 | 2020-12-23 | FMC Corporation | PYRROLIDINONE AND METHOD FOR MANUFACTURING THEREOF |
| AR111967A1 (en) | 2017-05-30 | 2019-09-04 | Fmc Corp | AMIDES HERBICIDES |
| AR111839A1 (en) | 2017-05-30 | 2019-08-21 | Fmc Corp | LACTAMAS 3-REPLACED HERBICIDES |
| JP7250686B2 (en) * | 2017-10-06 | 2023-04-03 | 武田薬品工業株式会社 | heterocyclic compound |
| US11447488B2 (en) | 2017-10-06 | 2022-09-20 | Takeda Pharmaceutical Company Limited | Heterocyclic compounds |
| EP4031552B1 (en) | 2019-09-16 | 2024-11-06 | Takeda Pharmaceutical Company Limited | Azole-fused pyridazin-3(2h)-one derivatives |
| WO2021229294A1 (en) * | 2020-05-15 | 2021-11-18 | Takeda Pharmaceutical Company Limited | Treatment for depression |
| CN113943294A (en) * | 2020-07-15 | 2022-01-18 | 成都海博为药业有限公司 | Compound serving as BTK inhibitor and preparation method and application thereof |
| WO2025226591A1 (en) | 2024-04-22 | 2025-10-30 | Neurocrine Biosciences, Inc. | Methods of administering 9-[4-(cyclohexyloxy)phenyl]-7-methyl-3,4-dihydropyrazino[2,1-c][1,2,4]thiadiazine 2,2-dioxide without side effects |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0437742Y2 (en) | 1986-10-22 | 1992-09-04 | ||
| JPH0285851A (en) | 1988-09-22 | 1990-03-27 | Konica Corp | Novel coupler for photography |
| JPH037742A (en) | 1989-06-05 | 1991-01-14 | Toyo Tire & Rubber Co Ltd | Rubber composition for rubber chain |
| JP2874960B2 (en) * | 1990-06-03 | 1999-03-24 | コニカ株式会社 | Silver halide photographic materials containing novel dyes |
| JPH04119890A (en) * | 1990-09-11 | 1992-04-21 | Konica Corp | Pyrazolothiadiazine dye |
| JP3430375B2 (en) * | 1993-11-12 | 2003-07-28 | コニカ株式会社 | Thermal transfer material and dye suitable for the material |
| DE19704923A1 (en) | 1997-02-10 | 1998-08-13 | Hoechst Schering Agrevo Gmbh | Pesticides containing glue |
| AU5271900A (en) | 1999-11-04 | 2001-05-14 | Colorado State University Research Foundation | Method and device for attracting insects |
| FR2801587B1 (en) | 1999-11-30 | 2002-01-11 | Adir | NOVEL BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| US7199118B2 (en) | 2001-10-10 | 2007-04-03 | Neurosearch A/S | Benzothiazine derivatives, their preparation and use |
| FR2833955B1 (en) * | 2001-12-21 | 2004-01-30 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2854634B1 (en) * | 2003-05-05 | 2005-07-08 | Servier Lab | NOVEL THIADIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| FR2865474B1 (en) | 2004-01-26 | 2008-06-13 | Servier Lab | NOVEL FLUORINATED BENZOTHIAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| FR2879201B1 (en) * | 2004-12-10 | 2007-02-16 | Servier Lab | NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| AU2007262661A1 (en) | 2006-06-23 | 2007-12-27 | Nufarm Australia Limited | Phenoxy alkanoate herbicidal composition and method of preparation and use |
| EP2102153A1 (en) * | 2006-12-11 | 2009-09-23 | Eli Lilly & Company | Ampa receptor potentiators |
| US20080167374A1 (en) | 2007-01-09 | 2008-07-10 | Loveland Products, Inc. | Pesticide composition and method of use |
| CN101910178A (en) | 2007-11-05 | 2010-12-08 | 先灵公司 | gamma secretase modulator |
| US8642660B2 (en) * | 2007-12-21 | 2014-02-04 | The University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| WO2009119088A1 (en) | 2008-03-25 | 2009-10-01 | 武田薬品工業株式会社 | Heterocyclic compound |
| JP2009248543A (en) * | 2008-04-11 | 2009-10-29 | Fujifilm Corp | Optical information recording medium and information recording method |
| TW201012803A (en) * | 2008-06-06 | 2010-04-01 | Organon Nv | Heterocyclic derivatives |
| WO2010054067A1 (en) | 2008-11-06 | 2010-05-14 | Schering Corporation | Gamma secretase modulators |
| TW201030002A (en) | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
| JP2012051806A (en) | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | Imidazolylpyrazine derivative |
| FR2943342B1 (en) | 2009-03-20 | 2011-03-04 | Servier Lab | NOVEL BENZOTHIADIAZEPINES DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| WO2010140339A1 (en) | 2009-06-01 | 2010-12-09 | 武田薬品工業株式会社 | Heterocyclic compound |
| JPWO2011007756A1 (en) | 2009-07-13 | 2012-12-27 | 武田薬品工業株式会社 | Heterocyclic compounds and uses thereof |
| WO2011036889A1 (en) | 2009-09-25 | 2011-03-31 | 武田薬品工業株式会社 | Heterocyclic compound |
| WO2011036885A1 (en) | 2009-09-25 | 2011-03-31 | 武田薬品工業株式会社 | Heterocyclic compound |
| PT2603513T (en) * | 2010-08-10 | 2020-06-08 | Takeda Pharmaceuticals Co | Heterocyclic compound and use thereof |
-
2011
- 2011-08-09 PT PT117499442T patent/PT2603513T/en unknown
- 2011-08-09 AR ARP110102905A patent/AR082618A1/en active IP Right Grant
- 2011-08-09 PE PE2013000244A patent/PE20131116A1/en active IP Right Grant
- 2011-08-09 EP EP11749944.2A patent/EP2603513B1/en active Active
- 2011-08-09 KR KR1020137006113A patent/KR101852215B1/en active Active
- 2011-08-09 CA CA2807460A patent/CA2807460C/en active Active
- 2011-08-09 LT LTEP11749944.2T patent/LT2603513T/en unknown
- 2011-08-09 SI SI201131887T patent/SI2603513T1/en unknown
- 2011-08-09 PL PL11749944T patent/PL2603513T3/en unknown
- 2011-08-09 US US13/206,113 patent/US8575154B2/en active Active
- 2011-08-09 BR BR112013002250-7A patent/BR112013002250B1/en active IP Right Grant
- 2011-08-09 TW TW100128311A patent/TWI504604B/en active
- 2011-08-09 NZ NZ607593A patent/NZ607593A/en unknown
- 2011-08-09 ES ES11749944T patent/ES2793723T3/en active Active
- 2011-08-09 HR HRP20200844TT patent/HRP20200844T1/en unknown
- 2011-08-09 DK DK11749944.2T patent/DK2603513T3/en active
- 2011-08-09 CN CN201180048970.3A patent/CN103180326B/en active Active
- 2011-08-09 HU HUE11749944A patent/HUE049460T2/en unknown
- 2011-08-09 SG SG2013007463A patent/SG187656A1/en unknown
- 2011-08-09 JP JP2013506362A patent/JP5788496B2/en active Active
- 2011-08-09 EA EA201390222A patent/EA022078B1/en not_active IP Right Cessation
- 2011-08-09 US US13/816,137 patent/US9150591B2/en active Active
- 2011-08-09 MA MA35708A patent/MA34509B1/en unknown
- 2011-08-09 AU AU2011290126A patent/AU2011290126B2/en active Active
- 2011-08-09 RS RS20200574A patent/RS60311B1/en unknown
- 2011-08-09 PH PH1/2013/500247A patent/PH12013500247A1/en unknown
- 2011-08-09 UY UY0001033551A patent/UY33551A/en not_active Application Discontinuation
- 2011-08-09 WO PCT/JP2011/068497 patent/WO2012020848A1/en not_active Ceased
- 2011-08-09 MY MYPI2013000428A patent/MY165908A/en unknown
- 2011-08-09 GE GEAP201113021A patent/GEP20156216B/en unknown
- 2011-08-09 CN CN201510259936.0A patent/CN104926837A/en active Pending
- 2011-08-09 MX MX2013001614A patent/MX349470B/en active IP Right Grant
- 2011-09-08 UA UAA201302884A patent/UA111594C2/en unknown
-
2013
- 2013-01-28 IL IL224452A patent/IL224452A/en active IP Right Grant
- 2013-02-05 DO DO2013000030A patent/DOP2013000030A/en unknown
- 2013-02-07 CL CL2013000380A patent/CL2013000380A1/en unknown
- 2013-02-12 ZA ZA2013/01120A patent/ZA201301120B/en unknown
- 2013-02-18 CR CR20130066A patent/CR20130066A/en unknown
- 2013-02-22 US US13/774,635 patent/US8778934B2/en active Active
- 2013-02-22 US US13/774,707 patent/US8916551B2/en active Active
- 2013-03-06 EC ECSP13012478 patent/ECSP13012478A/en unknown
- 2013-03-07 CO CO13046020A patent/CO6680700A2/en active IP Right Grant
-
2014
- 2014-11-13 US US14/540,699 patent/US20150073137A1/en not_active Abandoned
-
2015
- 2015-07-21 US US14/804,935 patent/US9499568B2/en active Active
- 2015-07-29 JP JP2015149216A patent/JP6113789B2/en active Active
-
2016
- 2016-10-10 US US15/289,650 patent/US9884875B2/en active Active
-
2017
- 2017-12-18 US US15/845,621 patent/US20180162875A1/en not_active Abandoned
-
2019
- 2019-01-24 US US16/256,773 patent/US10654874B2/en active Active
-
2020
- 2020-03-23 US US16/827,316 patent/US11279713B2/en active Active
- 2020-05-25 CY CY20201100475T patent/CY1123507T1/en unknown
-
2024
- 2024-03-01 US US18/592,897 patent/US20240360156A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20131116A1 (en) | AMPA ENHANCING HETEROCYCLIC COMPOUNDS | |
| PE20121617A1 (en) | OXAZINE DERIVATIVES AS BACE INHIBITORS | |
| PE20130405A1 (en) | PIRAZOL-4-IL-HETEROCICLIL-CARBOXAMIDE COMPOUNDS AND METHODS OF USE | |
| PE20160127A1 (en) | ACID COMPOUND (2S, 3S) -3 - ((2- (5-FLUORO-1H-PIRROLO [2,3-B] PYRIDIN-3-IL) -5-FLUOROPYRIMIDIN-4-IL) AMINO) BICICLO [2.2. 2] OCTANE-2-CARBOXYL AS AN INHIBITOR OF THE REPLICATION OF THE FLU VIRUS TO H1N1, H2N2, H3N2 or H5N1 | |
| UY35395A (en) | TETRACYCLIC BROMODOMINES INHIBITORS | |
| PE20141685A1 (en) | NOVEL DIHYDROPYRIMIDINOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEM FOR THE TREATMENT OF INFLAMMATORY DISORDERS | |
| CO6541569A2 (en) | N1-PIRAZOLOESPIROCETONA ACETIL-COA CARBOXYLASE INHIBITORS | |
| ECSP13013038A (en) | ACETIL-COA CARBOXILASA REPLACED INHIBITORS | |
| DOP2014000152A (en) | BROMODOMINIUM INHIBITORS | |
| ECSP10010582A (en) | AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
| UY33694A (en) | ? N1 / N2-LACTAMA ACETIL-COA CARBOXYLASE INHIBITORS ?. | |
| EA201101671A1 (en) | SUBSTITUTED DERIVATIVES OF AMINOPROPIONIC ACID AS NEPRILISIN INHIBITORS | |
| PA8825301A1 (en) | CONDENSED CYCLOPENTANOCARBOXYLIC ACID DERIVATIVES SUBSTITUTED WITH ACILAMINE AND ITS USE AS PHARMACEUTICAL PRODUCTS | |
| MX2013005533A (en) | Substituted amino bisphenyl pentanoic acid derivatives as nep inhibitors. | |
| EA201101672A1 (en) | SUBSTITUTED DERIVATIVES OF AMINOISAL ACID AS NEPRILISIN INHIBITORS | |
| CO6382125A2 (en) | QUINASE PROTEIN INHIBITORS | |
| ECSP15012804A (en) | ALCOXYPYRAZOLES AS SOLUBLE GUANILATE CYCLASE ACTIVATORS | |
| EA201200763A1 (en) | SUBSTITUTED DERIVATIVES OF CARBAMOILMETYLAMINO ACID ACID AS NEW INHIBITORS NEP | |
| EA201300250A1 (en) | OXADIAZOL INHIBITORS OF LEUKOTRIEN PRODUCTION | |
| EA201101621A1 (en) | DERIVATIVES OF BENZOXAZOLONE AS ALDOSTERON SYNTHASE INHIBITORS | |
| PH12015501752A1 (en) | Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors | |
| PE20142450A1 (en) | DIFLUORO-HEXAHYDRO-CYCLOPENTAOXACINYLS AND DIFLUORO-HEXAHYDRO-BENZOOXACINYLS AS BACE1 INHIBITORS | |
| EA201101301A1 (en) | SODIUM SALT 5-CYCLOPROPYL-2 - {[2- (2,6-DIFTORPHENYL) PYRIMIDIN-5-IL] AMINO} BENZOIC ACID AS DHODH INHIBITORS | |
| PE20151782A1 (en) | DERIVATIVES OF AZAQUINOLIN-CARBOXAMIDE | |
| CY1116518T1 (en) | 1,2,4-Triazolone derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |